Vyant Bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 0.119 million compared to USD 0.165 million a year ago. Net loss was USD 1.63 million compared to USD 5.81 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.74 a year ago. Basic loss per share was USD 0.26 compared to USD 0.99 a year ago.
For the six months, revenue was USD 0.199 million compared to USD 0.468 million a year ago. Net loss was USD 6.11 million compared to USD 14.97 million a year ago. Basic loss per share from continuing operations was USD 0.95 compared to USD 1.5 a year ago. Basic loss per share was USD 0.97 compared to USD 2.55 a year ago.